Notice: This company has been marked as potentially delisted and may not be actively trading. Tesaro (TSRO) News Today Add Compare Share Share Headlines Stock Analysis All Sources Trusted Sources MarketBeat Benzinga Bloomberg GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 May 2022 April 2022 March 2022 February 2022 January 2022 Time Period Hedge Fund - Ivory Capital (Investment Mgmt)October 17, 2024 | insidermonkey.comBiopharma Cred. Regulatory NewsAugust 3, 2024 | lse.co.ukGilbert H Kliman's Net WorthMay 17, 2024 | benzinga.comKeval Desai's Net WorthFebruary 22, 2024 | benzinga.comTesaro (TSRO) Stock Slumps on Public Offering, Leerink Lifts Price TargetSeptember 14, 2023 | thestreet.comAnalysts Holding As Pfizer Waits On Two Phase 3 Studies (TSRO)Pfizer has two products with great potential, waiting on phase-3 study results. The resulting revenue increase should also improve share value.February 24, 2023 | marketbeat.comDr. Marc Siegel Explains Why Tesaro (TSRO) Cancer Drug Is a Big DealJanuary 3, 2023 | thestreet.comImmunotherapy Drugs Market Worth $475+ Billion, Globally, by 2028 at 14+% CAGR | The Insight Partners - PR NewswireOctober 18, 2022 | prnewswire.comAnaptysBio and GSK-partnered immuno-oncology agents JEMPERLI (dostarlimab-gxly) and cobolimab show positive progress in two separate non-small cell lung cancer trials - Yahoo FinanceOctober 5, 2022 | finance.yahoo.comANAPTYSBIO, INC : Entry into a Material Definitive Agreement, Regulation FD Disclosure, Financial Statements and Exhibits (form 8-K) - Marketscreener.comSeptember 12, 2022 | marketscreener.comDay One Appoints Garry Nicholson as Chairman of the Board of Directors - Yahoo FinanceSeptember 12, 2022 | finance.yahoo.comGlaxoSmithKline : GSK to highlight the latest advances in cancer research from across its portfolio and pipeline at ESMO - Marketscreener.comSeptember 1, 2022 | marketscreener.comNorth America oncology market value to cross USD 246 billion by 2028 - GlobeNewswireAugust 9, 2022 | globenewswire.comGlobal TIM3 Inhibitors Drug Clinical Trials & Market Opportunities Report 2022: Market to Surpass $1 Billion by 2028, Driven by the First Drug Approval Expected to be Launched by 2024 - Yahoo FinanceAugust 8, 2022 | finance.yahoo.comTIM3 Inhibitors Drug Clinical Trials Research Report 2022: Insight on Emerging TIM3 Inhibitors in Development As Monotherapy & Combination Therapy - PR NewswireAugust 6, 2022 | prnewswire.comTIM3 Inhibitors Drug Clinical Trials Research Report 2022: Insight on Emerging TIM3 Inhibitors in Development As Monotherapy & Combination Therapy - Yahoo FinanceAugust 5, 2022 | finance.yahoo.comTIM3 Inhibitors Drug Clinical Trials & Market Opportunity Insights Report 2022-2028 - ResearchAndMarkets.com - Business WireAugust 4, 2022 | businesswire.comTIM3 Inhibitors Drug Clinical Trials & Market Opportunity Insight 2028 - Yahoo FinanceJuly 21, 2022 | finance.yahoo.comTIM3 Inhibitors Drug Clinical Trials & Market Opportunity Insight 2028 - GlobeNewswireJuly 21, 2022 | globenewswire.comAnti TIM3 Inhibitors Drugs Antibody Clinical Trials Market Report 2028 - GlobeNewswireJuly 20, 2022 | globenewswire.comMetastatic Castration-Resistant Prostate Cancer Clinical Trial Pipeline Insights | DelveInsight - GlobeNewswireJuly 11, 2022 | globenewswire.comMary Lynne Hedley Elected to Lilly Board of Directors - GuruFocus.comJune 25, 2022 | gurufocus.comXilio Therapeutics (XLO) Announces Promotion of Martin Huber, MD, to President - StreetInsider.comJune 16, 2022 | streetinsider.comJanssen to Highlight Science, Innovation and Advances in Robust Oncology Portfolio and Pipeline Through More Than 60 Data Presentations at ASCO and EHA - PR NewswireMay 31, 2022 | prnewswire.comMary Lynne Hedley Elected to Lilly Board of Directors - Yahoo FinanceMay 8, 2022 | finance.yahoo.comMary Lynne Hedley Elected to Lilly Board of Directors - StreetInsider.comMay 7, 2022 | streetinsider.comEli Lilly & Co. (LLY) Appoints Mary Lynne Hedley to its Board - StreetInsider.comMay 6, 2022 | streetinsider.comMary Lynne Hedley Elected to Lilly Board of Directors - PR NewswireMay 6, 2022 | prnewswire.comJanssen Submits Marketing Authorisation Application to EMA Seeking Approval of Niraparib and Abiraterone Acetate Dual Action Tablet Plus Prednisone for the Treatment of Patients with HRR Gene-Mutated Metastatic Castration Resistant Prostate Cancer - Business WireApril 28, 2022 | businesswire.comGSK Agrees to Buy Sierra Oncology for $1.9 Billion in Cash - BloombergApril 13, 2022 | bloomberg.comDel. Justices Uphold Toss Of Suit Over Tesaro's $5.1B Sale - Law360April 9, 2022 | law360.comSofinnova Investments Announces the Addition of Dr. Chris Carpenter as Executive Partner - Business WireApril 7, 2022 | businesswire.com3 CEOs to Invest In - NasdaqApril 1, 2022 | nasdaq.comClovis Oncology: Forging A Fresh Perspective - Seeking AlphaMarch 31, 2022 | seekingalpha.comTesaro Sale Flaws Justify Case Remand, Del. Justices Told - Law360March 30, 2022 | law360.comGlobal Ovarian Cancer Drugs Market to 2031 - Featuring AstraZeneca, Roche and Tesaro Among Others - Yahoo FinanceMarch 29, 2022 | finance.yahoo.com$3.25 Billion Worldwide Ovarian Cancer Drugs Industry 2022 - Identify Growth Segments for Investment - ResearchAndMarkets.com - Yahoo FinanceMarch 28, 2022 | finance.yahoo.comOvarian Cancer Drugs Global Market Report 2022 - Yahoo FinanceMarch 16, 2022 | finance.yahoo.comEPIZYME, INC. : Change in Directors or Principal Officers, Regulation FD Disclosure, Financial Statements and Exhibits (form 8-K) - Marketscreener.comMarch 15, 2022 | marketscreener.comZai Lab: Shares Are Cheap, But Not Without Reason - Seeking AlphaMarch 9, 2022 | seekingalpha.comCatamaran Bio Announces Appointment of Michael DeRidder, PhD, as Senior Vice President, Corporate Strategy and New Product Planning - Business WireFebruary 28, 2022 | businesswire.comJanssen Presents New Data Demonstrating the Combination of Niraparib and Abiraterone Acetate Plus Prednisone Significantly Improved Radiographic Progression-Free Survival as a First-Line Therapy in Patients with HRR Gene-Mutated Metastatic Castrati - PRNewswireFebruary 14, 2022 | prnewswire.comJanssen Data at ASCO GU Demonstrate Longstanding Leadership in Prostate Cancer and Commitment to Advancing Potential New Therapeutic Options for Genitourinary Cancers - PRNewswireFebruary 1, 2022 | prnewswire.comCancer Supportive Care Drugs Market to Reach $24.40 Bn, Globally, by 2030 at 2.2% CAGR: Allied Market Research - PRNewswireJanuary 20, 2022 | prnewswire.comGlobal Pharma and Biotech Preclinical Stage Partnering Deals Directory 2021: Comprehensive Access to Deals and Contract Documents for Over 2,400 Deals - Yahoo FinanceJanuary 15, 2022 | finance.yahoo.comGlobal Pharma and Biotech Preclinical Stage Partnering Deals Directory 2021 - GlobeNewswireJanuary 14, 2022 | globenewswire.comWomen's Health Therapeutics Market Report Up to 2031: Visiongain Research Inc - GlobeNewswireJanuary 12, 2022 | globenewswire.comSleep Aids Market is expected to register a CAGR of 4.5% during the forecast period (2021-2031) - Benzing - BenzingaDecember 3, 2021 | benzinga.comPoly (ADP-Ribose) Polymerase Inhibitors Pipeline Research Report 2021: Comprehensive Insights About 20+ Companies and 20+ Pipeline Drugs - ResearchAndMarkets.com - Yahoo FinanceDecember 2, 2021 | finance.yahoo.comPoly (ADP-Ribose) Polymerase Inhibitors Pipeline Research Report 2021: Comprehensive Insights About 20+ Companies and 20+ Pipeline Drugs - ResearchAndMarkets.com - Business WireDecember 1, 2021 | businesswire.com Get Tesaro News Delivered to You Automatically Sign up to receive the latest news and ratings for TSRO and its competitors with MarketBeat's FREE daily newsletter. Email Address URGENT: This Altcoin Opportunity Won’t Wait – Act Now (Ad)Crypto has officially entered the "banana zone" – that wild phase where prices can 1000x in days. It happens like clockwork every 4 years, during the December to February window of a Bitcoin halving year. This is where fortunes are made – often LITERALLY overnight. >> Register for the Workshop Now TSRO Media Mentions By Week TSRO Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. TSRO News Sentiment▼0.000.60▲Average Medical News Sentiment TSRO News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. TSRO Articles This Week▼00▲TSRO Articles Average Week Get Tesaro News Delivered to You Automatically Sign up to receive the latest news and ratings for TSRO and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies UTHR News Today INCY News Today NBIX News Today BMRN News Today EXAS News Today EXEL News Today RGEN News Today MDGL News Today HALO News Today IONS News Today Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:TSRO) was last updated on 12/22/2024 by MarketBeat.com Staff From Our PartnersThis Crypto Is Set to Explode in DecemberIt's a groundbreaking opportunity that could be poised for extraordinary gains. The catalyst behind this su...Crypto 101 Media | SponsoredDid You See Trump’s Bombshell Exec. Order 001?Starting with what I call Exec. Order 001. It’s a bombshell law that I believe Trump will sign within minut...Banyan Hill Publishing | SponsoredWARNING: “Buffett Indicator” flashing for first time in 50 yearsWarren Buffett has sold a staggering $97 billion worth of stocks this year... But why? Our research indi...Behind the Markets | SponsoredYour bank is lying to you.You might think you have your money in a high-yield savings account, but do you really? The national average A...MyBankTracker | SponsoredRare "crisis signal" triggers for third time in U.S. marketA rare pattern has just repeated for the third time in U.S. history. The last two times this happened, the...Stansberry Research | SponsoredAI breakthrough about to upend industryEveryone is talking about AI right now. The talk has been endless ever since ChatGPT was released to the m...Porter & Company | SponsoredCould This Tiny Device Help You Make an Extra $30k a Year?I believe it’s going to power Elon Musk’s next AI revolution… A revolution he believes will be worth more t...Brownstone Research | SponsoredElon Musk’s chilling warning for humanityThe 'invasion' I've discovered has nothing to do with the border crisis. What's happening at our southern bord...The Freeport Society | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Tesaro, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Tesaro With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free TSRO Stock Alerts